HEALTHCARE ROYALTY PARTNERS
We are a $3.0+ billion global healthcare investment firm. We invest primarily in commercial stage healthcare product assets that have significant clinical value, strong barriers to entry and that are marketed by some of the world’s largest pharmaceutical companies. Over the past decade, our senior investment team has completed more than 60 royalty investments valued in excess of $2.5 billion. For more information, visit www.healthcareroyalty.com.
HEALTHCARE ROYALTY PARTNERS
Social Links:
Industry:
Asset Management Biotechnology Financial Services Medical Device Pharmaceutical
Founded:
2007-01-01
Status:
Active
Contact:
203.487.8300
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Domain Not Resolving Wordpress Plugins
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-08 | Clearside Biomedical | HealthCare Royalty Partners investment in Post-IPO Debt - Clearside Biomedical | 65 M USD |
| 2022-06-30 | Ardelyx | HealthCare Royalty Partners investment in Post-IPO Debt - Ardelyx | 20 M USD |
| 2022-06-16 | Rhythm Pharmaceuticals | HealthCare Royalty Partners investment in Post-IPO Debt - Rhythm Pharmaceuticals | 37.5 M USD |
| 2021-09-30 | Spero Therapeutics | HealthCare Royalty Partners investment in Post-IPO Debt - Spero Therapeutics | 125 M USD |
| 2019-03-04 | Portola Pharmaceuticals | HealthCare Royalty Partners investment in Post-IPO Debt - Portola Pharmaceuticals | 125 M USD |
| 2019-01-08 | Coherus Biosciences | HealthCare Royalty Partners investment in Post-IPO Debt - Coherus Biosciences | 75 M USD |
| 2016-04-14 | TearScience | HealthCare Royalty Partners investment in Series D - TearScience | 19.23 M USD |
| 2015-02-13 | Invuity | HealthCare Royalty Partners investment in Private Equity Round - Invuity | 22.9 M USD |
| 2014-11-13 | Helomics | HealthCare Royalty Partners investment in Series E - Helomics | 60 M USD |
| 2014-09-18 | Cardiorentis | HealthCare Royalty Partners investment in Series A - Cardiorentis | 45 M EUR |
More informations about "HealthCare Royalty Partners"
Team | HealthCare Royalty Partners
HealthCare Royalty Partners team is comprised of former pharmaceutical executives, physicians, bankers, equity analysts, lawyers and consultants. ... our Senior Advisor Board consists of …See details»
HealthCare Royalty Partners - Crunchbase
HealthCare Royalty Partners may be growing as evidenced by the closing of an additional debt-focused fund, which indicates an increase in their financial activities and potential for revenue …See details»
HealthCare Royalty Partners - Org Chart, Teams, Culture & Jobs
HealthCare Royalty Partners (“HCR”) is a private investment firm that purchases royalties and uses debt-like structures to invest in commercial or near-commercial stage biopharmaceutical …See details»
HealthCare Royalty Partners - Investments, Portfolio & Company …
HealthCare Royalty Partners is a global investment firm that partners with healthcare companies, non-profit institutions and inventors. Search Crunchbase. Start Free Trial . Chrome Extension. …See details»
Royalty Monetization | HealthCare Royalty Partners
HealthCare Royalty Partners is a leading royalty monetization firm that has been structuring and executing these transactions for more than a decade. HealthCare Royalty. Home; ... HCRx has considerable experience working with …See details»
HealthCare Royalty Partners - Funding, Financials, …
HealthCare Royalty Partners has raised a total of $3.3B across 2 funds, their latest being Healthcare Royalty Partners IV. This fund was announced on Nov 13, 2019 and raised a total of obfuscatedSee details»
HealthCare Royalty Partners investment portfolio
HealthCare Royalty Partners's latest investment was on 06-Feb-2023 in AstraZeneca (Global Rights to Movantik), a company within the Buildings and Property industry. Data Transparency. Meet our data hygiene team. Discover …See details»
HealthCare Royalty Partners Raises $1.8 Billion
Jan 9, 2020 HealthCare Royalty Partners Carlos Almodóvar, 203-487-8300 [email protected] Release Summary HealthCare Royalty Partners raises $1.83 billion for its new flagship fund and affiliated entities.See details»
John Urquhart - Partner - HealthCare Royalty Partners
Senior Managing Director at HealthCare Royalty Partners · Experience: HealthCare Royalty Partners · Education: University of Pennsylvania - The Wharton School · Location: Boston · 500 ...See details»
Healthcare Royalty Partners III: Fund Performance - PitchBook
Oct 21, 2014 Healthcare Royalty Partners III is a buyout fund managed by HealthCare Royalty Partners. The fund is based in Stamford, Connecticut and invested in Europe, Asia and North …See details»
Sagard Healthcare Royalty Partners Closes $725 Million First Fund
Feb 18, 2021 SOURCE Sagard Healthcare Royalty Partners. For press inquiries, contact: ... Organization Profile. Sagard Healthcare Royalty Partners. Contact Cision. 866-245-2317 from …See details»
Portfolio | HealthCare Royalty Partners
HealthCare Royalty Partners portfolio of investments span the pharmaceutical, biotechnology and specialty pharmaceutical sectors.See details»
Sagard closes $725 million for biopharmaceutical royalty …
Feb 18, 2021 Sagard Holdings, the alternative asset manager arm of Power Corporation, has announced the final close of Sagard Healthcare Royalty Partners, LP (SHRP), pulling in $725 …See details»
Healthcare Private Equity: A Review of Key Case Studies and
Jun 19, 2024 PE’s primary aim of generating returns for investors have often led to tensions between their profit motives and the intrinsic values of the healthcare services they are …See details»
Sagard Healthcare Royalty Partners - Crunchbase
Sagard Healthcare Royalty Partners focuses on post-IPO debt investments in biotechnology, pharmaceutical, and biopharma industries, with a geographical focus in North America, …See details»
Sentara Healthcare awards more than $5 million to support nearly …
More than $10 million in investments through Sentara’s 2022 grant cycles are working to advance health equity and create healthier communities Sentara Healthcare today announced an …See details»
Sentara Health - Wikipedia
Sentara Health is a not-for-profit healthcare organization serving Virginia, northeastern North Carolina and Florida. It is based in Hampton Roads, Virginia and offers services in 12 acute …See details»
Sagard Holdings announces first closing of Sagard Healthcare …
Jan 9, 2020 "We are very pleased with this strong first close for Sagard Healthcare Royalty Partners, ... Organization Profile. Sagard Healthcare Royalty Partners. Contact Cision. 866 …See details»
Sentara Northern Virginia Medical Center names new president
Joyner is returning to the Washington metropolitan area having held healthcare leadership positions that include: Vice President, Professional Services at Sibley Memorial Hospital in …See details»